What is Karuna Labs?
Karuna Labs operates at the intersection of neuroscience and digital health, providing the KarunaHOME platform. This solution offers evidence-based, non-pharmacological interventions for individuals suffering from chronic pain and acquired brain injuries. By utilizing neuroplastic pain management techniques, the company enables patients to retrain their neural pathways through a structured 12-week program. The platform is uniquely positioned to serve a broad spectrum of stakeholders, including individual patients, health plans, and workers' compensation providers, effectively bridging the gap between clinical efficacy and accessible digital care.
How much funding has Karuna Labs raised?
Karuna Labs has raised a total of $3.1M across 2 funding rounds:
Angel/Seed
$3M
Debt
$136K
Angel/Seed (2019): $3M with participation from Correlation Ventures, Baseline Ventures, Anorak Ventures, Hustle Fund, Dreamit Ventures, and AET Fund
Debt (2021): $136K led by PPP
Key Investors in Karuna Labs
Correlation Ventures
Correlation Ventures utilizes advanced data science to facilitate rapid investment decisions, supporting high-growth companies in transforming their respective industries.
Baseline Ventures
Baseline Ventures is a specialized firm with deep expertise in brand licensing, strategic partnerships, and sports marketing, providing significant value to its portfolio companies.
Anorak Ventures
Anorak Ventures is a California-based venture capital firm focused on deep technology sectors, including artificial intelligence, robotics, and augmented reality.
What's next for Karuna Labs?
With the recent infusion of capital, Karuna Labs is poised to accelerate its market penetration and enhance its technological infrastructure. The strategic focus will likely shift toward deepening partnerships with large-scale health plans and workers' compensation providers, where the demand for non-surgical, cost-effective pain management solutions is at an all-time high. As the company continues to refine its neuroplasticity-based algorithms, it is expected to solidify its role as a leader in the digital therapeutics sector, potentially setting new standards for patient outcomes in chronic pain management.
See full Karuna Labs company page
